Package 31722-832-31

{"route": ["ORAL"], "spl_id": "2b44d151-5b10-9250-e063-6294a90a53c2", "openfda": {"upc": ["0331722832601"], "unii": ["4P3T9QF9NZ"], "rxcui": ["313566"], "spl_set_id": ["383e8810-b877-4a4f-abdf-c8c4c8e394f8"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 TABLET, FILM COATED in 1 BLISTER PACK (31722-832-31)", "package_ndc": "31722-832-31", "marketing_start_date": "20160318"}, {"sample": false, "description": "10 TABLET, FILM COATED in 1 CARTON (31722-832-32)", "package_ndc": "31722-832-32", "marketing_start_date": "20160318"}, {"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (31722-832-60)", "package_ndc": "31722-832-60", "marketing_start_date": "20160318"}], "brand_name": "Valganciclovir", "product_id": "31722-832_2b44d151-5b10-9250-e063-6294a90a53c2", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "DNA Polymerase Inhibitors [MoA]", "Nucleoside Analog Antiviral [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "31722-832", "generic_name": "Valganciclovir", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Valganciclovir", "active_ingredients": [{"name": "VALGANCICLOVIR HYDROCHLORIDE", "strength": "450 mg/1"}], "application_number": "ANDA205166", "marketing_category": "ANDA", "marketing_start_date": "20160318", "listing_expiration_date": "20261231"}